Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7294613 Beta-defensins

Patent 7294613 was granted and assigned to ZymoGenetics on November, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David A. Adler0

Nand Baindur0

James L. Holloway0

Paul O. Sheppard0

Stephanie Beigel-Orme0

Date of Patent

November 13, 2007

0

Patent Application Number

100911660

Date Filed

March 5, 2002

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to polynucleotide and polypeptide molecules for zamp1, a novel member of the β-defensin family. The polypeptides, and polynucleotides encoding them, exhibit anti-microbial activity and may be used in the study or treatment of microbial infections. The present invention also includes antibodies to the zamp1 polypeptides.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7294613 Beta-defensins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.